Debra L. Monticciolo
Research Subjects
Debra L. Monticciolo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Rodney L. Hajdik
Department of Radiology, Scott and White Healthcare, Texas A&M College of Medicine, Temple, TX, USA
2 shared publicationsSpencer T. Sincleair
Department of Radiology, Scott and White Healthcare, Texas A&M College of Medicine, Temple, TX, USA
2 shared publicationsAshley K. Gist
Department of Radiology, Scott and White Healthcare, Texas A&M College of Medicine, Temple, TX, USA
1 shared publicationJames B. Schnitker
Department of Radiology, Scott and White Healthcare, Texas A&M College of Medicine, Temple, TX, USA
1 shared publicationKelly Biggs
Department of Radiology, Scott and White Healthcare, Texas A&M College of Medicine, Temple, TX, USA
1 shared publicationLee S. Caplan
Morehouse School of Medicine, Prevention Research Center, Atlanta, Georgia
1 shared publication
Latest Publications
- 1 June 2012
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 198 (6) , W618-W620
Postbiopsy Confirmation of MR-Detected Lesions Biopsied Using Ultrasound
OBJECTIVE. The purpose of this article is to outline a quick and effective method of confirming MR-sonographic correlation for lesions detected with MRI but percutaneously biopsied using ultrasound. CONCLUSION. Ensuring that a lesion seen on targeted ultrasound is the same as that detected at MRI can be difficult. For benign concordant lesions, a mismatch may only be discovered at 6-month postbiopsy MRI follow-up. However, lesion correlation can be established on the same day as biopsy by obtaining a single unenhanced T1-weighted non–fat-saturated pulse sequence just after percutaneous ultrasound-guided biopsy. Scanning time is less than 4 minutes. Postbiopsy changes and the biopsy clip are easily seen and help verify MR-sonographic lesion correlation.
- 1 June 2012
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 198 (6) , W618-W620
Postbiopsy Confirmation of MR-Detected Lesions Biopsied Using Ultrasound
OBJECTIVE. The purpose of this article is to outline a quick and effective method of confirming MR-sonographic correlation for lesions detected with MRI but percutaneously biopsied using ultrasound. CONCLUSION. Ensuring that a lesion seen on targeted ultrasound is the same as that detected at MRI can be difficult. For benign concordant lesions, a mismatch may only be discovered at 6-month postbiopsy MRI follow-up. However, lesion correlation can be established on the same day as biopsy by obtaining a single unenhanced T1-weighted non–fat-saturated pulse sequence just after percutaneous ultrasound-guided biopsy. Scanning time is less than 4 minutes. Postbiopsy changes and the biopsy clip are easily seen and help verify MR-sonographic lesion correlation.
- 1 August 2011
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 32 (4) , 319-330
Magnetic Resonance Imaging of the Breast for Cancer Diagnosis and Staging
- 1 August 2011
- Published by Elsevier in Seminars in Ultrasound, CT and MRI
- Vol. 32 (4) , 319-330
Magnetic Resonance Imaging of the Breast for Cancer Diagnosis and Staging
- 10 February 2011
- Published by Hindawi Limited in The Breast Journal
- Vol. 17 (2) , 187-190
Breast Conserving Therapy with Accelerated Partial Breast versus External Beam Whole Breast Irradiation: Comparison of Imaging Sequela and Complications in a Matched Population
Our purpose was to evaluate and compare the imaging sequela and complications of accelerated partial breast irradiation (APBI) with those occurring in patients treated with standard external beam therapy. Patient selection included those who met the criteria for possible ABPI: age 45 or older; cancer stage T1N0M0 or ductal carcinoma in situ 3 cm or less, and negative surgical margins. One hundred and ninety seven had complete records and films available for review. Ninety-seven (49%) were treated with APBI (MammoSite) and 100(51%) were treated with external beam. Image findings for APBI versus external beam were: distortion 90(93%) versus 83(83%), seroma 67(69%) versus 7(7%), skin edema 52(54%) versus 47(47%), increased stroma 75(77%) versus 66(66%), calcifications 10(10%) versus 6(6%), and fat necrosis 12(12%) versus 6(6%). For APBI, skin and stromal edema was more commonly focal. At imaging, the seroma rate was statistically and significantly different between the two treatment modes (p < 0.0001). For patients treated with APBI, seroma formation was not related to balloon size and only weakly related to lumpectomy cavity size. The complication rate was significantly higher for those treated with APBI (36 versus 20%) and the types and treatment of complications differed. There were three recurrences among the APBI group and none among those treated with external beam radiation.
- 10 February 2011
- Published by Hindawi Limited in The Breast Journal
- Vol. 17 (2) , 187-190
Breast Conserving Therapy with Accelerated Partial Breast versus External Beam Whole Breast Irradiation: Comparison of Imaging Sequela and Complications in a Matched Population
Our purpose was to evaluate and compare the imaging sequela and complications of accelerated partial breast irradiation (APBI) with those occurring in patients treated with standard external beam therapy. Patient selection included those who met the criteria for possible ABPI: age 45 or older; cancer stage T1N0M0 or ductal carcinoma in situ 3 cm or less, and negative surgical margins. One hundred and ninety seven had complete records and films available for review. Ninety-seven (49%) were treated with APBI (MammoSite) and 100(51%) were treated with external beam. Image findings for APBI versus external beam were: distortion 90(93%) versus 83(83%), seroma 67(69%) versus 7(7%), skin edema 52(54%) versus 47(47%), increased stroma 75(77%) versus 66(66%), calcifications 10(10%) versus 6(6%), and fat necrosis 12(12%) versus 6(6%). For APBI, skin and stromal edema was more commonly focal. At imaging, the seroma rate was statistically and significantly different between the two treatment modes (p < 0.0001). For patients treated with APBI, seroma formation was not related to balloon size and only weakly related to lumpectomy cavity size. The complication rate was significantly higher for those treated with APBI (36 versus 20%) and the types and treatment of complications differed. There were three recurrences among the APBI group and none among those treated with external beam radiation.
- 1 May 2010
- Published by Hindawi Limited in The Breast Journal
- Vol. 16 (4) , 424-7
Rib Fracture as a Complication of Accelerated Partial Breast Irradiation Diagnosed on MRI
- 1 May 2010
- Published by Hindawi Limited in The Breast Journal
- Vol. 16 (4) , 424-7
Rib Fracture as a Complication of Accelerated Partial Breast Irradiation Diagnosed on MRI
- 28 February 2010
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 7 (2) , 132-137
The ACR Diagnostic Radiology In-Training Examination: Evolution, Current Status, and Future Directions
- 28 February 2010
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 7 (2) , 132-137
The ACR Diagnostic Radiology In-Training Examination: Evolution, Current Status, and Future Directions
- 1 January 2005
- Published by Hindawi Limited in The Breast Journal
- Vol. 11 (1) , 9-14
Histologic Grading at Breast Core Needle Biopsy: Comparison with Results from the Excised Breast Specimen
The purpose of this study was to evaluate the correlation between histologic tumor grade obtained at breast core needle biopsy (CNB) with that obtained from the excised breast specimen. A total of 899 records from all patients with breast cancer from January 1999 to January 2003 were reviewed. Of these, 341 lesions had CNB for diagnosis and had pathology results prospectively graded for both the core and excised specimens. Patient age, lesion type and size, imaging method for biopsy, number of cores, core pathology, surgery performed, final diagnosis, nuclear grade, and combined grade were recorded. In 286 lesions (83.9%), nuclear grade was reported for both core and excised specimens. Of these, 219 (76.6%) were in agreement. Of the 67 that differed, 66 (98.5%) differed by one grade; 46 (68.7%) were upgraded. The groups did not differ in average tumor size, tumor pathology, or number of cores. In 288 lesions (84.5%), combined grade was reported for both core and excised specimens. Of these, 214 (74.3%) were in agreement. Of the 74 that differed, 71 (95.9%) differed by one grade and 50 (67.6%) were upgraded. Again, there were no significant differences in tumor size, type, or number of cores. Overall, nuclear grade and combined grade obtained at CNB each showed agreement with the corresponding excised specimen grading approximately 75% of the time. Grading obtained by CNB, if changed by pathologic evaluation of the excised tumor, is most commonly upgraded. Differences, when they occurred, could not be attributed to tumor size, type, or the number of cores obtained.
- 1 January 2005
- Published by Hindawi Limited in The Breast Journal
- Vol. 11 (1) , 9-14
Histologic Grading at Breast Core Needle Biopsy: Comparison with Results from the Excised Breast Specimen
The purpose of this study was to evaluate the correlation between histologic tumor grade obtained at breast core needle biopsy (CNB) with that obtained from the excised breast specimen. A total of 899 records from all patients with breast cancer from January 1999 to January 2003 were reviewed. Of these, 341 lesions had CNB for diagnosis and had pathology results prospectively graded for both the core and excised specimens. Patient age, lesion type and size, imaging method for biopsy, number of cores, core pathology, surgery performed, final diagnosis, nuclear grade, and combined grade were recorded. In 286 lesions (83.9%), nuclear grade was reported for both core and excised specimens. Of these, 219 (76.6%) were in agreement. Of the 67 that differed, 66 (98.5%) differed by one grade; 46 (68.7%) were upgraded. The groups did not differ in average tumor size, tumor pathology, or number of cores. In 288 lesions (84.5%), combined grade was reported for both core and excised specimens. Of these, 214 (74.3%) were in agreement. Of the 74 that differed, 71 (95.9%) differed by one grade and 50 (67.6%) were upgraded. Again, there were no significant differences in tumor size, type, or number of cores. Overall, nuclear grade and combined grade obtained at CNB each showed agreement with the corresponding excised specimen grading approximately 75% of the time. Grading obtained by CNB, if changed by pathologic evaluation of the excised tumor, is most commonly upgraded. Differences, when they occurred, could not be attributed to tumor size, type, or the number of cores obtained.
- 10 March 2004
- Published by Hindawi Limited in The Breast Journal
- Vol. 10 (2) , 106-110
The American College of Radiology's BI-RADS 3 Classification in a Nationwide Screening Program: Current Assessment and Comparison with Earlier Use
The Breast Imaging Reporting and Data System allows radiologists to classify lesions as “probably benign—short interval follow‐up suggested” (category 3). The purpose of this study is to evaluate the recent use of the category 3 designation in a national cancer detection program. We analyzed data from the National Breast and Cervical Cancer Early Detection Program, a nationwide collaboration between the Centers for Disease Control and Prevention (CDC) and local health agencies that provides cancer screening for low‐income, uninsured women. The study population included all women at least 40 years old who had mammograms in the program through September 1999 (n = 826,424). Of the 826,424 mammograms, the percentage classified as category 3 in the initial phase (1991–1996, previously reported, n = 372,760) was 7.7%; of the most recent 453,664 mammograms (1996–1999), 6.0% were given this designation. During the same periods, the percentage of abnormal mammograms decreased from 2.6% to 2.1% and those needing “additional imaging” (category 0) increased from 5.0% to 6.9%. The percentage receiving a category 3, category 0, or abnormal designation decreased with increasing age for each classification. The percentage of category 3 mammograms varied by site from 1.1% to 12.2%. Overall the proportions of category 3 mammograms decreased over time, while requests for additional examinations increased. This suggests that patients were more likely than before to receive additional examinations prior to their final designation. The persistent wide variability in category 3 indicates further education and attention to the use of this category is warranted.
- 10 March 2004
- Published by Hindawi Limited in The Breast Journal
- Vol. 10 (2) , 106-110
The American College of Radiology's BI-RADS 3 Classification in a Nationwide Screening Program: Current Assessment and Comparison with Earlier Use
The Breast Imaging Reporting and Data System allows radiologists to classify lesions as “probably benign—short interval follow‐up suggested” (category 3). The purpose of this study is to evaluate the recent use of the category 3 designation in a national cancer detection program. We analyzed data from the National Breast and Cervical Cancer Early Detection Program, a nationwide collaboration between the Centers for Disease Control and Prevention (CDC) and local health agencies that provides cancer screening for low‐income, uninsured women. The study population included all women at least 40 years old who had mammograms in the program through September 1999 (n = 826,424). Of the 826,424 mammograms, the percentage classified as category 3 in the initial phase (1991–1996, previously reported, n = 372,760) was 7.7%; of the most recent 453,664 mammograms (1996–1999), 6.0% were given this designation. During the same periods, the percentage of abnormal mammograms decreased from 2.6% to 2.1% and those needing “additional imaging” (category 0) increased from 5.0% to 6.9%. The percentage receiving a category 3, category 0, or abnormal designation decreased with increasing age for each classification. The percentage of category 3 mammograms varied by site from 1.1% to 12.2%. Overall the proportions of category 3 mammograms decreased over time, while requests for additional examinations increased. This suggests that patients were more likely than before to receive additional examinations prior to their final designation. The persistent wide variability in category 3 indicates further education and attention to the use of this category is warranted.